Stay updated on Apalutamide Study in High-Risk Prostate Cancer Clinical Trial

Sign up to get notified when there's something new on the Apalutamide Study in High-Risk Prostate Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Apalutamide Study in High-Risk Prostate Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    A service alert has been added regarding planned maintenance starting July 25th, during which most services will be unavailable for over 24 hours.
    Difference
    4%
    Check dated 2025-07-11T17:18:54.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The page has been updated to version 2.16.5, and the previous version 2.16.4 has been removed. Notably, the information regarding the modernization of ClinicalTrials.gov data ingest scheduled for July 2025 has been deleted.
    Difference
    4%
    Check dated 2025-07-04T13:04:22.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The date has been updated from May 23, 2025, to June 22, 2025.
    Difference
    0.6%
    Check dated 2025-06-27T08:11:34.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The expected modernization date for the ClinicalTrials.gov data ingest has been pushed back from June 2025 to July 2025.
    Difference
    4%
    Check dated 2025-06-20T04:51:22.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.2 to version 2.16.3.
    Difference
    0.3%
    Check dated 2025-06-13T00:47:33.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.1 to version 2.16.2.
    Difference
    0.3%
    Check dated 2025-06-05T19:40:25.000Z thumbnail image

Stay in the know with updates to Apalutamide Study in High-Risk Prostate Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Apalutamide Study in High-Risk Prostate Cancer Clinical Trial page.